Bexil Cp Stock Current Valuation
| BXLCDelisted Stock | USD 30.25 0.00 0.00% |
Valuation analysis of Bexil Cp helps investors to measure Bexil Cp's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Bexil Cp's price fluctuation is very steady at this time. Calculation of the real value of Bexil Cp is based on 3 months time horizon. Increasing Bexil Cp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bexil Cp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bexil Pink Sheet. However, Bexil Cp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 30.25 | Real 25.45 | Hype 30.25 |
The real value of Bexil Pink Sheet, also known as its intrinsic value, is the underlying worth of Bexil Cp Company, which is reflected in its stock price. It is based on Bexil Cp's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bexil Cp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bexil Cp helps investors to forecast how Bexil pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bexil Cp more accurately as focusing exclusively on Bexil Cp's fundamentals will not take into account other important factors: Bexil Cp Company Current Valuation Analysis
Bexil Cp's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Bexil Cp Current Valuation | (4.8 M) |
Most of Bexil Cp's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bexil Cp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Bexil Cp has a Current Valuation of (4.8 Million). This is 100.01% lower than that of the Diversified Financial Services sector and 100.06% lower than that of the Financials industry. The current valuation for all United States stocks is 100.03% higher than that of the company.
Bexil Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bexil Cp's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bexil Cp could also be used in its relative valuation, which is a method of valuing Bexil Cp by comparing valuation metrics of similar companies.Bexil Cp is currently under evaluation in current valuation category among its peers.
Bexil Fundamentals
| Return On Equity | -0.0277 | ||||
| Return On Asset | -0.0367 | ||||
| Profit Margin | (1.74) % | ||||
| Operating Margin | (3.73) % | ||||
| Current Valuation | (4.8 M) | ||||
| Shares Outstanding | 1.02 M | ||||
| Price To Earning | 3.63 X | ||||
| Price To Book | 0.74 X | ||||
| Price To Sales | 71.78 X | ||||
| Revenue | 418.6 K | ||||
| Gross Profit | 8.7 M | ||||
| EBITDA | (1.2 M) | ||||
| Net Income | 6.49 M | ||||
| Cash And Equivalents | 21.21 M | ||||
| Cash Per Share | 28.17 X | ||||
| Total Debt | 2.48 K | ||||
| Current Ratio | 74.38 X | ||||
| Book Value Per Share | 33.53 X | ||||
| Cash Flow From Operations | 2.21 M | ||||
| Earnings Per Share | 7.99 X | ||||
| Number Of Employees | 10 | ||||
| Beta | 0.36 | ||||
| Market Capitalization | 30.81 M | ||||
| Total Asset | 38.22 M | ||||
| Retained Earnings | 25.09 M | ||||
| Working Capital | 37.85 M | ||||
| Current Asset | 38.09 M | ||||
| Current Liabilities | 245 K |
About Bexil Cp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bexil Cp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bexil Cp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bexil Cp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Bexil Pink Sheet
If you are still planning to invest in Bexil Cp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bexil Cp's history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |